Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8581 | 1170 | 49.8 | 87% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RUBOXISTAURIN | Author keyword | 9 | 48% | 1% | 13 |
2 | PENN MOL STUDIES KIDNEY DIS | Address | 7 | 32% | 1% | 17 |
3 | BEETHAM EYE OPHTHALMOL | Address | 4 | 75% | 0% | 3 |
4 | LY333531 | Author keyword | 4 | 50% | 1% | 6 |
5 | DISCOVERY PHARMACOL GRP 1KONOHANA KU | Address | 3 | 60% | 0% | 3 |
6 | DIABETIC RENAL HYPERTROPHY | Author keyword | 2 | 67% | 0% | 2 |
7 | PROGRESSIVE NEPHROPATHIES | Author keyword | 2 | 67% | 0% | 2 |
8 | NEPHROL OSTEOL | Address | 1 | 15% | 1% | 9 |
9 | CHEM SYNTH S | Address | 1 | 38% | 0% | 3 |
10 | ALLERGY INFLAMMAT PROGRAM | Address | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RUBOXISTAURIN | 9 | 48% | 1% | 13 | Search RUBOXISTAURIN | Search RUBOXISTAURIN |
2 | LY333531 | 4 | 50% | 1% | 6 | Search LY333531 | Search LY333531 |
3 | DIABETIC RENAL HYPERTROPHY | 2 | 67% | 0% | 2 | Search DIABETIC+RENAL+HYPERTROPHY | Search DIABETIC+RENAL+HYPERTROPHY |
4 | PROGRESSIVE NEPHROPATHIES | 2 | 67% | 0% | 2 | Search PROGRESSIVE+NEPHROPATHIES | Search PROGRESSIVE+NEPHROPATHIES |
5 | PKC BETA II INHIBITORS | 1 | 100% | 0% | 2 | Search PKC+BETA+II+INHIBITORS | Search PKC+BETA+II+INHIBITORS |
6 | PKC BETA INHIBITOR | 1 | 50% | 0% | 2 | Search PKC+BETA+INHIBITOR | Search PKC+BETA+INHIBITOR |
7 | GLOMERULAR MESANGIAL CELLS | 1 | 13% | 1% | 10 | Search GLOMERULAR+MESANGIAL+CELLS | Search GLOMERULAR+MESANGIAL+CELLS |
8 | ORYEONGSAN | 1 | 40% | 0% | 2 | Search ORYEONGSAN | Search ORYEONGSAN |
9 | PROTEIN KINASE C BETA | 1 | 13% | 1% | 6 | Search PROTEIN+KINASE+C+BETA | Search PROTEIN+KINASE+C+BETA |
10 | DIABETIC KIDNEY | 1 | 21% | 0% | 3 | Search DIABETIC+KIDNEY | Search DIABETIC+KIDNEY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIACYLGLYCEROL MASS | 33 | 74% | 2% | 25 |
2 | HIGH GLUCOSE | 23 | 11% | 16% | 193 |
3 | LY333531 | 15 | 68% | 1% | 13 |
4 | PKC BETA INHIBITOR | 13 | 39% | 2% | 27 |
5 | IV COLLAGEN PRODUCTION | 9 | 59% | 1% | 10 |
6 | AUTOCRINE ACTIVATION | 9 | 40% | 1% | 17 |
7 | INCREASED COLLAGEN PRODUCTION | 7 | 50% | 1% | 10 |
8 | HIGH GLUCOSE CONDITIONS | 7 | 41% | 1% | 13 |
9 | MATRIX GENE EXPRESSION | 5 | 14% | 3% | 35 |
10 | RENAL HYPERTROPHY | 5 | 15% | 3% | 31 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications | 2010 | 179 | 135 | 31% |
Protein kinase C activation and the development of diabetic complications | 1998 | 725 | 96 | 40% |
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy | 2011 | 109 | 135 | 30% |
Diabetic nephropathy: Mechanisms of renal disease progression | 2008 | 224 | 50 | 40% |
The role of protein kinase C activation and the vascular complications of diabetes | 2007 | 145 | 150 | 39% |
Molecular mechanisms of diabetic renal hypertrophy | 1999 | 260 | 128 | 41% |
Protein kinase C and the development of diabetic vascular complications | 2001 | 175 | 152 | 38% |
Molecular understanding of hyperglycemia's adverse effects for diabetic complications | 2002 | 424 | 145 | 17% |
Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice | 2009 | 24 | 76 | 51% |
Diabetic nephropathy and transforming growth factor-beta: Transforming our view of glomerulosclerosis and fibrosis build-up | 2003 | 126 | 127 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PENN MOL STUDIES KIDNEY DIS | 7 | 32% | 1.5% | 17 |
2 | BEETHAM EYE OPHTHALMOL | 4 | 75% | 0.3% | 3 |
3 | DISCOVERY PHARMACOL GRP 1KONOHANA KU | 3 | 60% | 0.3% | 3 |
4 | NEPHROL OSTEOL | 1 | 15% | 0.8% | 9 |
5 | CHEM SYNTH S | 1 | 38% | 0.3% | 3 |
6 | ALLERGY INFLAMMAT PROGRAM | 1 | 50% | 0.2% | 2 |
7 | BRAIN KOREA BK PLUS TEAM 21 | 1 | 50% | 0.2% | 2 |
8 | MED RENAL ELE OLYTE HYPERTENS | 1 | 100% | 0.2% | 2 |
9 | MEDPENN MOLEC STUDIES KIDNEY DIS MED | 1 | 100% | 0.2% | 2 |
10 | UNIDAD HIPERTENSAO | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000211767 | VASOHIBIN 1//VASOHIBIN//VASOHIBIN 2 |
2 | 0.0000141553 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |
3 | 0.0000135631 | KANEMATSU//ISOLATED GLOMERULI//NEPHROL A |
4 | 0.0000133719 | THY 1 NEPHRITIS//GLOMERULAR BIOENGN UNIT//MESANGIAL CELL |
5 | 0.0000132433 | DIABETIC GLOMERULOPATHY//NON DIABETIC RENAL DISEASE//STRUCTURAL FUNCTIONAL RELATIONSHIPS |
6 | 0.0000131936 | URINARY IGF I//RENAL HYPERTROPHY//SUB MOL ENDOCRINOL |
7 | 0.0000129140 | MOL DIABET//GDD GED TOXICOL//HARVARD PROGRAM THER EUT SCI |
8 | 0.0000088226 | PHYSIOL MORPHOL//RAT AORTAE//CHARLIE NORWOOD VET ADM MED |
9 | 0.0000086916 | HYPERTENS RENAL EXCELLENCE//URINARY ANGIOTENSINOGEN//RECEPTOR SIGNAL TRANSDUCT |
10 | 0.0000079630 | AGGREGATED PROTEIN//IMMUNOGLOBULIN G COMPLEXES//MESANGIUM |